Bayer to raise further $7bn to fund $63bn Monsanto acquisition

By Pouyan Broukhim

Leverkusen-based Bayer has announced that is looking to raise a final $7bn in fresh capital in order to finance the company’s $63bn takeover of US agrochemicals giant Monsanto.

The news comes after Bayer last week won US approval for the takeover, with the merger set to create the world’s largest seeds and pesticides manufacturing company, boasting of annual sales of approximately $23.5bn.

See also:

“The acquisition of Monsanto is a strategic milestone in strengthening our portfolio of leading businesses in health and nutrition,” said Werner Baumann, Chairman of the Board of Management of Bayer AG.

“We will double the size of our agriculture business and create a leading innovation engine in agriculture, positioning us to better serve our customers and unlock the long-term growth potential in the sector.”

The company is aiming to secure these new funds as the agreements previously signed in September 2016 stipulate that after 14 June Monsanto could withdraw from the deal and seek a higher price.

With this in mind, the deal is expected to conclude 7 June.


Featured Articles

Amelia DeLuca, CSO at Delta Air Lines on Female Leadership

Driving decarbonisation at Delta Air Lines, Chief Sustainability Officer Amelia DeLuca discusses the rise of the CSO and value of more women in leadership

Liz Elting – Driving Equality & Building Billion-$ Business

Founder and CEO Liz Elting Turned Her Passion into Purpose and Created a Billion-Dollar Business While Fighting for Workplace Equality – and Winning

JPMorgan Chase: Committed to supporting the next generation

JPMorgan has unveiled a host of new and expanded philanthropic activities totalling US$3.5 million to support the development of apprenticeship programmes

How efficient digital ecosystems became business critical

Technology & AI

Mastercard: Supporting clients at a time of rapid evolution

Digital Strategy

Why Ceridian has boldly rebranded to Dayforce

Human Capital